製品名:(R)-4-methyl-1,3,2-dioxathiolane 2,2-dioxide

IUPAC Name:(4R)-4-methyl-1,3,2λ⁶-dioxathiolane-2,2-dione

CAS番号:1006381-03-8
分子式:C3H6O4S
純度:97%
カタログ番号:CM199586
分子量:138.14

包装単位 有効在庫 価格(USD) 数量
CM199586-1g in stock źƄ
CM199586-5g in stock ȎǯĽ
CM199586-25g in stock źŔƞ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:1006381-03-8
分子式:C3H6O4S
融点:-
SMILESコード:C[C@H]1OS(OC1)(=O)=O
密度:
カタログ番号:CM199586
分子量:138.14
沸点:
MDL番号:
保管方法:

Column Infos

Orforglipron
Obesity is becoming an increasingly serious public health problem globally, plaguing millions of people and significantly increasing their risk of chronic diseases such as diabetes and heart disease. In recent years, with the approval of new weight loss drugs such as Wegovy (Semaglutide) and Mounjaro (Tirzepatide), people's attention to this field has once again heated up, spawning an upsurge in the research and development of new treatments. There are currently nearly 70 obesity treatments in the research and development stage. Eli Lilly's Orforglipron is the world's first oral small molecule GLP-1RA to start Phase III clinical trials.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.